CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 6 incoming connections
- PositionReturn on equity is -21.5%, lower than 95% of its Diagnostics & Research peers (median 1.1%)
- FinancialsAltman Z-Score 3.11: safe zone
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.91BCNY580.89M · vs all stocks (USD)
Revenue (TTM)
971.32MCNY144.45M · vs all stocks (USD)
Profit Margin
-21.67%vs Diagnostics & Research peers
52-Week Change
-49.40%vs all stocks
Market Capitalization
3.91BCNY580.89M · vs all stocks (USD)
Enterprise Value
3.64BCNY541.89M · vs all stocks (USD)
Forward P/E
18.60xvs Diagnostics & Research peers
Price to Sales (TTM)
4.02xvs Diagnostics & Research peers
Price to Book (MRQ)
3.69xvs Diagnostics & Research peers
Enterprise to Revenue
3.75xvs Diagnostics & Research peers
Enterprise to EBITDA
-88.37xvs Diagnostics & Research peers
Gross Margin
25.16%vs Diagnostics & Research peers
Profit Margin
-21.67%vs Diagnostics & Research peers
Operating Margin
-6.16%vs Diagnostics & Research peers
Return on Assets (TTM)
-2.06%vs Diagnostics & Research peers
Return on Equity (TTM)
-21.47%vs Diagnostics & Research peers
Revenue (TTM)
971.32MCNY144.45M · vs all stocks (USD)
Revenue per Share (TTM)
4.80CNYUpdated Aug 21, 2026Quarterly Revenue Growth
-36.80%vs Diagnostics & Research peers
Gross Profit (TTM)
207.78MCNY30.90M · vs all stocks (USD)
EBITDA (TTM)
-41.23MCNY-6.13M · vs all stocks (USD)
Net Income (TTM)
-210.48MCNY-31.30M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-53.45%vs Diagnostics & Research peers
Operating Cash Flow (TTM)
-1.52MCNY-226.64K · vs all stocks (USD)
Payout Ratio
0.00%vs Diagnostics & Research peers
Minority Interest (Equity)
-40.20MCNYFY2025 · Dec 31, 2025Revenue
1.08BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
836.63MCNYFY2025 · Dec 31, 2025Gross Profit
240.33MCNYFY2025 · Dec 31, 2025Operating Income
-58.04MCNY-8.63M · vs all stocks (USD)
Pre-tax Income
-152.36MCNYFY2025 · Dec 31, 2025Income Tax Expense
49.08MCNYFY2025 · Dec 31, 2025Net Income
-201.44MCNYFY2025 · Dec 31, 2025EBIT
-118.84MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
-10.85MCNYFY2025 · Dec 31, 2025Research & Development
41.78MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
100.53MCNYFY2025 · Dec 31, 2025Other Operating Expenses
15.56MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
3.38MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
33.53MCNYFY2025 · Dec 31, 2025EPS (Basic)
-1.04CNYFY2025 · Dec 31, 2025EPS (Diluted)
-1.04CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
199.31MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
199.31MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-201.44MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-5.84MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-51.57MCNYFY2025 · Dec 31, 2025Free Cash Flow
-57.16MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
122.10MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-201.44MCNYFY2025 · Dec 31, 2025Other Non-cash Items
40.78MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-32.03MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
141.12MCNYFY2025 · Dec 31, 2025Capital Expenditures
-5.59MCNYFY2025 · Dec 31, 2025Net Acquisitions
40.40MCNYFY2025 · Dec 31, 2025Purchase of Investments
-33.69MCNYFY2025 · Dec 31, 2025Sale of Investments
4.01MCNYFY2025 · Dec 31, 2025Other Investing Activity
25.07MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
30.21MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
317.83MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-326.70MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-18.56MCNYFY2025 · Dec 31, 2025Other Financing Charges
-39.73MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-67.15MCNYFY2025 · Dec 31, 2025Shares Outstanding
218.08MSharesUpdated Aug 21, 2026Float Shares
186.03MSharesUpdated Aug 21, 2026% Held by Insiders
17.16%vs all stocks
% Held by Institutions
4.26%vs all stocks
Total Cash (MRQ)
137.25MCNY20.41M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.6270CNYUpdated Aug 21, 2026Total Debt (MRQ)
376.40MCNY55.97M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.3816xvs Diagnostics & Research peers
Current Ratio (MRQ)
1.61xvs Diagnostics & Research peers
Book Value per Share (MRQ)
4.69CNYUpdated Aug 21, 2026Total Assets
1.80BCNY268.04M · vs all stocks (USD)
Total Current Assets
1.24BCNYFY2025 · Dec 31, 2025Total Liabilities
897.96MCNYFY2025 · Dec 31, 2025Total Non-current Assets
564.08MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
25.19MCNYFY2025 · Dec 31, 2025Total Current Liabilities
872.77MCNYFY2025 · Dec 31, 2025Cash
121.92MCNYFY2025 · Dec 31, 2025Cash Equivalents
9.01MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
130.94MCNYFY2025 · Dec 31, 2025Other Short-term Investments
1.35MCNYFY2025 · Dec 31, 2025Accounts Receivable
734.08MCNYFY2025 · Dec 31, 2025Inventory
223.38MCNYFY2025 · Dec 31, 2025Accounts Payable
260.82MCNYFY2025 · Dec 31, 2025Short-term Debt
436.66MCNYFY2025 · Dec 31, 2025Other Current Liabilities
3.88MCNYFY2025 · Dec 31, 2025Long-term Debt
19.39MCNYFY2025 · Dec 31, 2025Common Stock (Book)
210.19MCNYFY2025 · Dec 31, 2025Retained Earnings
-162.27MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
904.49MCNY134.51M · vs all stocks (USD)
Treasury Stock
24.03MCNYFY2025 · Dec 31, 202552-Week Low
12.92CNYUpdated Aug 21, 202652-Week High
38.12CNYUpdated Aug 21, 202652-Week Change
-49.40%vs all stocks
50-Day MA
15.61CNYUpdated Aug 21, 2026200-Day MA
20.36CNYUpdated Aug 21, 2026Avg 10-Day Volume
24.50MSharesUpdated Aug 21, 2026Avg 30-Day Volume
25.44MSharesUpdated Aug 21, 2026Diluted EPS (TTM)
-1.05CNYUpdated Aug 21, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Return on equity is -21.5%, lower than 95% of its Diagnostics & Research peers (median 1.1%)Significant
Return on equity: -0.21Industry median: 0.01Industry P5: -0.21Peers compared: 31.00
Financial Health
Altman Z-Score 3.11: safe zoneNotable
Altman Z-Score: 3.11
Supply Chain
Midstream position: 6 outgoing, 6 incoming connectionsNotable
Outgoing: 6.00Incoming: 6.00
High connectivity hub: 12 industry connectionsNotable
Total Connections: 12.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Ceepower Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Nantong Chaoda Equipment Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Krishana Phoschem Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Wuxi Holyview Microelectronics Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Gree Electric Appliances, Inc.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Eastern Communications Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Southern Cable Group Berhad
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shenzhen Chuangyitong Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Wuxi Jinyang New Materials Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Eizo Corporation
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking